734-936-8000 - Service Desk | Request Support

MC3 Recorded Education Series: Attention Deficit Hyperactivity Disorder

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Educational Materials
Evaluation
Release Date: Wed, 1/1/20
Termination Date: Thu, 12/31/20
Credits: 2.25
Educational Objectives: After completing this activity participants will be able to identify the diagnostic
criteria for attention deficit hyperactivity disorder, have an approach to the evaluation of youth with suspected attention deficit hyperactivity disorder, as well as understand the evidence-based nonpharmacologic and pharmacologic management strategies to treat attention deficit hyperactivity disorder in youth.
Target Audience: This activity is appropriate for House Officers, Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians, Social Workers in the fields of Primary Care, Psychiatry, Psychology, Sleep Medicine, Social Work.
Accreditation Information:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Original Release Date: April 2019

Termination Date: March 2022

Additional Info: Presenter:
Nasuh Malas, MD, MPH

Educational Planner:
Anne Kramer, MSW

Educational Co-Planners:
Erin Hughes Kramer, MSW
Nasuh Malas, MD, MPH

Financial Disclosures:
There are no relevant financial relationships with ACCME-defined commercial interests to disclose for this activity.

References:
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5thEdition. Arlington, VA. American Psychiatric Association 2013

Correll CU, Kratochvil CJ, March JS. "Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics." Journal of Clinical Psychiatry 2011. 72(5): 655-670

Polanczyk, G Epidemiology of ADHD across the lifespan. Curr Opinion Psych 20(386-92); 2007

Vitiello B, et al. (2007). Effectiveness of methylphenidatein the 10-month continuation phase of the preschoolers with ADHD treatmentstudy (PATS). Journal of Child and Adolescent Psychopharmacology, 17(5): 593-603.

Martin, A. Lewis's Child and Adolescent psychiatry, a comprehensive textbook, Fourth Ed. 2007.

The MTA cooperative Group. "A 14 month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder." Arch of Gen Psychiatry, 1999; 56;1073-1086.

Credits available:

AMA PRA Category 1: 2.25
Participation: 2.25